Clinical Trial Update: Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for HSV-1 M032 in children and adults with newly diagnosed diffuse midline glioma after standard radiation; study status is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Midline Glioma

Drugs mentioned

• HSV-1 M032 (engineered herpes simplex virus type 1 (M032))

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioma | Phase 1 | Status: NOT_YET_RECRUITING